30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Daniel Vitt

Track

Insider profile

Currently holds a position at Immunic Inc

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 28% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President, Chief Executive Officer, Director Immunic Inc April 12, 2019 -
Daniel Vitt's trades of Immunic Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-06 2025-06-04
US Immunic Inc (IMUX)
B Purchase
57,790 +4.5%
493.34
US$2,992,171 		57,790 +4.5% 493.34 US$2,992,171
2024-02-28 2024-02-26
US Immunic Inc (IMUX)
B Purchase
50,828 -27.1%
320.60
US$2,195,035 		50,828 -27.1% 320.60 US$2,195,035
2022-11-23 2022-11-22
US Immunic Inc (IMUX)
B Purchase
15,366 -36.0%
336.55
US$95,026 		15,366 -36.0% 336.55 US$95,026
2022-06-06 2022-06-03
US Immunic Inc (IMUX)
B Purchase
5,000 +1.4%
3.10
US$15,500 		5,000 +1.4% 3.10 US$15,500
2020-07-22 2020-07-21
US Immunic Inc (IMUX)
PlS Planned sale
1,300 -0.4%
15.62
US$20,310 		1,300 -0.4% 15.62 US$20,310
2020-07-22 2020-07-20
US Immunic Inc (IMUX)
PlS Planned sale
5,000 -1.4%
14.44
US$72,200 		5,000 -1.4% 14.44 US$72,200